S
SINOVAC BIOTECH LTD
SVACIK 0001084201NasdaqAcceleratedPharmaceutical PreparationsB9AGFY ends Dec 31
Period
FY 2024
Revenue
$361.37M
Net Income
$40.66M
Total Assets
$12.34B
Equity
$8.26B
Shares Out
71.86M
Op. Cash Flow
$-56.89M
Business
SINOVAC BIOTECH LTD is a foreign private issuer in Pharmaceutical Preparations, headquartered in Antigua and Barbuda. Shares trade on Nasdaq under the ticker SVA.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2024, period end 2024-12-31). Full statement history unavailable for this entity.
| Revenue | $361.37M |
| Net income | $40.66M |
| Total assets | $12.34B |
| Total liabilities | $2.04B |
| Stockholders' equity | $8.26B |
| Operating cash flow | $-56.89M |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro